CHRONIC PULMONARY ASPERGILLOSIS
Clinical trials for CHRONIC PULMONARY ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC PULMONARY ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for CHRONIC PULMONARY ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare lung infection: weekly shot shows promise
Disease control OngoingThis study tests a drug called rezafungin for people with a long-term lung infection caused by a fungus (chronic pulmonary aspergillosis) who have run out of treatment options. About 60 adults will receive the drug once a week for 6 months. Researchers will check if the infection…
Matched conditions: CHRONIC PULMONARY ASPERGILLOSIS
Phase: PHASE2 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Vitamin D's hidden role in TB and fungal lung disease revealed
Knowledge-focused OngoingThis study looks at whether vitamin D levels are linked to certain immune markers in people with active tuberculosis (TB), with or without a chronic fungal lung infection called aspergillosis. Researchers will compare blood samples from 300 participants—including healthy voluntee…
Matched conditions: CHRONIC PULMONARY ASPERGILLOSIS
Sponsor: Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan • Aim: Knowledge-focused
Last updated May 26, 2026 10:49 UTC